Items stated in the management plan
Partially revisedEach line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
In the Medical and Healthcare-related businesses, we determined that it would temporarily be difficult to secure the sales and operating profit originally planned because upfront investment associated with launching new businesses and the response to highly challenging projects have taken longer than expected. In addition, the outlook for the external environment has become uncertain due to the impact of U.S. tariff policies, fluctuations in oil market conditions, and other factors.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan (FY2024–FY2026) |
| Plan period | FY2024-FY2026 |
| Progress against the plan | Partially revised |
| Sales Target | ¥36,000 million → ¥35,000 million |
| Operating profit target | ¥3,600 million → ¥3,300 million |
| Operating profit margin target | 10.0％ → 9.4％ |
| Segment target | Segment Semiconductors and Mechatronics / Sales Target ¥13,000 million → ¥13,000 million / Operating profit target Not disclosed, Segment Medical and Healthcare / Sales Target ¥10,000 million → ¥7,500 million / Operating profit target Not disclosed, Segment Environment and social infrastructure / Sales Target ¥13,000 million → ¥14,500 million / Operating profit target Not disclosed |
| Plan assumptions | Upfront investment associated with launching new businesses in the Medical and Healthcare-related businesses, and the prolonged response to highly challenging projects. Uncertainty regarding the outlook for the external environment due to the impact of U.S. tariff policies since last year, fluctuations in oil market conditions, and other factors. |
| Key initiatives | Upfront investment associated with launching new businesses, Strengthening the competitiveness of each business and sustainably enhancing corporate value |
| Results under the previous plan | ¥36,000 million → Not disclosed |
| Reason for revision or withdrawal | In the Medical and Healthcare-related businesses, we determined that it would temporarily be difficult to secure the sales and operating profit originally planned because upfront investment associated with launching new businesses and the response to highly challenging projects have taken longer than expected. In addition, the outlook for the external environment has become uncertain due to the impact of U.S. tariff policies, fluctuations in oil market conditions, and other factors. |
| Risks identified | Impact of U.S. tariff policies, Fluctuations in oil market conditions, Uncertainty regarding the outlook for the external environment |
| Date of board resolution | 13 May 2026 |
| Publication date | 13 May 2026 |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Medical and Healthcare-related businesses, upfront investment associated with launching new businesses and the response to highly challenging projects have taken longer than expected, making it temporarily difficult to secure the sales and operating profit set out in the original plan. In addition, the outlook for the external environment has become uncertain due to the impact of U.S. tariff policies and fluctuations in oil market conditions, among other factors.